IBB ETF holdings (NASDAQ) - Page 11 | MetaTrader

Abrir gráfico completo

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

LAB Standard BioTools, Inc. 2.18 M 2.65 M 0.02%

CATX Perspective Therapeutics, Inc. 2.17 M 636.24 K 0.02%

SLN Silence Therapeutics plc 2.04 M 185.78 K 0.02%

OABI OmniAb, Inc. 2.04 M 828.10 K 0.02%

AVIR Atea Pharmaceuticals, Inc. 2.04 M 437.95 K 0.02%

LXEO Lexeo Therapeutics, Inc. 2.03 M 435.05 K 0.02%

IMRX Immuneering Corp. 1.93 M 387.58 K 0.02%

UPB Upstream Bio, Inc. 1.77 M 256.13 K 0.02%

LCTX Lineage Cell Therapeutics, Inc. 1.73 M 1.32 M 0.02%

AVXL Anavex Life Sciences Corp. 1.64 M 631.75 K 0.02%

FULC Fulcrum Therapeutics, Inc. 1.46 M 398.07 K 0.02%

KROS Keros Therapeutics, Inc. 1.37 M 128.50 K 0.02%

CDXS Codexis, Inc. 1.34 M 593.66 K 0.01%

ARCT Arcturus Therapeutics Holdings, Inc. 1.23 M 183.75 K 0.01%

VYGR Voyager Therapeutics, Inc. 1.22 M 348.40 K 0.01%

QTRX Quanterix Corp. 1.21 M 280.44 K 0.01%

NBP NovaBridge Biosciences 1.15 M 591.38 K 0.01%

LRMR Larimar Therapeutics, Inc. 1.13 M 370.52 K 0.01%

PYXS Pyxis Oncology, Inc. 1.13 M 374.68 K 0.01%

HUMA Humacyte, Inc. 1.12 M 1.44 M 0.01%

1
...
6
7
8
9
10
11
12
13

Notícias

UBS lista 5 motivos principais pelos quais ações de biotecnologia de médio porte devem se destacar em 2026